3 This trend mirrors consumer demand for GLP-1s for weight loss, which is higher in the U.S
For In Vitro Research Use Only Not for Human or Veterinary Use Intended Use: This product is intended exclusively for in vitro laboratory research
When prescribed, it is typically given as a small subcutaneous injection, often timed in the evening to align with the body's natural nighttime growth-hormone release
23,24 The GLP-1R, like other G protein-coupled receptors (GPCRs), undergoes inactivation following stimulation
A Flexible Savings Account is similar but is typically provided through your employer
For most, this medication may be better suited for maintenance dosing or for those pursuing GLP-1 therapy for non-weight-loss-related benefits or limited weight loss (generally less than 5% of total body weight)